Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. Sep 14, 2022; 28(34): 5023-5035
Published online Sep 14, 2022. doi: 10.3748/wjg.v28.i34.5023
Table 2 Maternal outcomes in the hepatitis C virus viremic group vs the control group
Variables, n (%)
HCV-infected group (n = 79), %
Healthy mother group (n = 115), %
P value
Pregnancy complications
Preterm (< 37 wk)1/79 (1.3)0/115 (0.0)> 0.99
Preeclampsia3/79 (3.8)0/115 (0.0)0.07
Eclampsia0/79 (0.0)2/115 (2.5)0.17
Gestational hypertension0/79 (0.0)4/115 (3.5)0.15
Abnormal thyroid function4/79 (5.1)1/115 (0.9)0.16
Gestational diabetes 4/79 (5.1)4/115 (3.5)0.72
Oligohydramnios6/79 (7.6)3/115 (2.6)0.16
Abnormal renal function49/79 (62.0)64/115 (55.7)0.38
Anemia during pregnancy15/79 (19.0)3/115 (2.6)< 0.001
Obstetric complications
Rates of cesarean section138/79 (48.1)32/115 (27.8)0.004
Nuchal cord27/79 (34.2)11/115 (9.6)< 0.001
Umbilical cord prolapses1/79 (1.3)0/115 (0.0)0.41
Postpartum hemorrhage1/79 (1.3)0/115 (0.0)0.41
Premature rupture of membranes3/79 (3.8)4/115 (3.5)> 0.99